Copyright: ©Author(s) 2026.
World J Clin Oncol. May 24, 2026; 17(5): 116662
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.116662
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.116662
Figure 8 Prognostic significance of CALD1 expression in triple-negative breast cancer.
Kaplan-Meier Plotter analysis showing the association between CALD1 expression and overall survival in patients with triple-negative breast cancer selected based on molecular subtypes (estrogen receptor-negative, progesterone receptor-negative, HER2-negative) and lymph node-positive status. Survival analyses were generated using all available probe sets per gene across eight Affymetrix probe IDs. High expression of CALD1 is represented by the red curve, whereas low expression of CALD1 is represented by the black curve. Each panel displays the corresponding hazard ratio and P value. P < 0.05 indicates statistical significance. HR: Hazard ratio.
- Citation: AlNuaimi A, Nair VA, Al-Khayyal N, Suliman A, Bou Malhab LJ, Hamoudi R, Hamad M, Talaat IM, Abdel-Rahman WM. Overexpression of low-molecular-weight caldesmon is associated with aggressive phenotypes and epithelial-mesenchymal transition in breast cancer cells. World J Clin Oncol 2026; 17(5): 116662
- URL: https://www.wjgnet.com/2218-4333/full/v17/i5/116662.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i5.116662